KCNH1
KCNH1 is a gene that encodes a protein known as potassium voltage-gated channel subfamily H member 1. This protein is a member of the voltage-gated potassium channel family, which plays a crucial role in the electrical activity of various cell types, including neurons and muscle cells.
Function[edit]
The KCNH1 gene provides instructions for making a protein that forms a channel across the cell membrane. This channel, known as the Ether-à-go-go (EAG) channel, allows potassium ions to flow out of cells. The movement of potassium ions through these channels is critical for maintaining the normal functions of cells, particularly nerve cells (neurons) in the brain.
Clinical significance[edit]
Mutations in the KCNH1 gene have been associated with Zimmerman-Laband syndrome and Temple-Baraitser syndrome. These are rare genetic disorders characterized by abnormalities in multiple body systems, including the nervous system. Mutations in the KCNH1 gene alter the function of the EAG channel, disrupting the flow of potassium ions in neurons. This disruption affects the normal electrical activity in the brain, leading to the neurological symptoms seen in these disorders.
See also[edit]
References[edit]
External links[edit]
- KCNH1 at the National Center for Biotechnology Information
| Genes on Human chromosome 1 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Human chromosome 1 related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian